NCT00859833 - Effects of Body Mass Index on the Hyperemic Response to Regadenoson | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

ObesityEndothelial DysfunctionDecreased Vascular Flow

Interventions

DRUG

Adenosine

Myocardial perfusion reserve measured with quantitative MRI during adenosine infusion (0.14 mg/kg/min x 6 minutes).

DRUG

Regadenoson

Myocardial perfusion reserve measured during regadenoson (0.4 mg/5 ml) bolus administration using quantitative perfusion MRI.

Trial Locations (1)

University of Utah, Salt Lake City